CAMBRIDGE, Mass.--(BUSINESS WIRE)--Delphia Therapeutics, Inc. (Delphia), announced its launch today to pioneer a new area of cancer biology – activation lethality – which targets cancer's surprising ...
Kevin Marks, PhD, has been involved in successful endeavors to create meaningful medicines over his 20-year career as a cancer drug hunter, including spells as the head of oncology drug discovery at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback